Gerresheimer AG, one of the world’s leading partners of the pharmaceutical and healthcare industry, has announced the acquisition of a majority shareholding in the Indian company Neutral Glass and Allied Industries.
Gerresheimer already has five plants in South America, seven in China and representative offices in Moscow and Mumbai, providing it with a strong presence in the emerging markets.
“The Indian pharmaceutical market is gaining in international significance and it is growing at an impressive rate," said Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG. "The acquisition of a majority shareholding in Neutral Glass will help us to strengthen our position in the emerging markets and to drive our growth in India,” he added.
Neutral Glass is one of the leading manufacturers of pharmaceutical primary glass packaging based in Mumbai, India, with a modern moulded glass plant in Kosamba, Gujarat Province. It produces pharmaceutical primary packaging products such as glass vials for liquid medications and infusions, as well as injection bottles. According to Gerresheimer, the company has acquired a 70% stake from the owner family, which has retained 30% of the shares.